HAPPY NEW YEAR!
Welcome to the January 2012 edition of the ISPOR eBulletin. The ISPOR eBulletin provides updates of recent ISPOR events and accomplishments. For more information, see: www.ispor.org.
Value in Health Regional Issues Journal
The ISPOR Board of Directors is proud to announce a new journal, Value in Health Regional Issues (VIHRI). The purpose of VIHRI is to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions in Asia, Latin America, Central & Eastern Europe, Western Asia, and Africa where the development and use of this science is emerging. For more information, see: Value in Health Regional Issues»
Value in Health Regional Issues Journal Co-Editors-in-Chief
The ISPOR Board of Directors is proud to announce Federico Augustovski, MD, MSc, PhD, Director, Economic Evaluations and HTA Department, Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina, and Bong-Min Yang, PhD, Professor, Health Economics School of Public Health, Seoul National University, Seoul, South Korea, as the first Co-Editors-in-Chief of the new ISPOR journal Value in Health Regional Issues. For more information, see: Value in Health Regional Issues »
ISPOR CONNECTIONS Editor-in-Chief: Call for Candidates
ISPOR is seeking qualified candidates for the position of 2012-2016 ISPOR CONNECTIONS Editor-in-Chief. If you are interested in responding to the ISPOR CONNECTIONS Editor-in-Chief Position Call for Candidates, email a letter of interest, addressed to the ISPOR Board of Directors, indicating relevant experience, and attach your curriculum vitae to: email@example.com by March 1, 2012. For more information, see: ISPOR CONNECTIONS Editor-in-Chief: Call for Candidates »
ISPOR Scientific Achievement Awards
Nominations are now being accepted for the following awards:
- ISPOR Avedis Donabedian Lifetime Achievement Award
- ISPOR Bernie J. O’Brien New Investigator Award
- ISPOR Award for Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research
- ISPOR Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research
If you would like to nominate a candidate or yourself for one of the four awards, please send in the required nomination materials to: firstname.lastname@example.org by FRIDAY, FEBRUARY 10, 2012. Nomination requirements and detailed award descriptions can be found at the ISPOR website at:
ISPOR Scientific Achievement Awards »
ISPOR 17th Annual International Meeting, Washington, DC, USA, June 2-6, 2012: CALL FOR ABSTRACTS DEADLINE: JANUARY 19, 2012
||FIRST PLENARY SESSION: COMPARING THE EFFECTIVENESS OF NEW DRUGS: SHOULD THE FDA BE ASKING 'DOES IT WORK' OR 'DOES IT WORK BETTER'?
Moderator/Speaker: Sean Tunis, MD, MSc, Founder & Director, Center for Medical Technology Policy, Baltimore, MD, USA
Speakers: Mark B. McClellan, MD, PhD, Director, Engelberg Center for Health Care Reform, Senior Fellow, Economic Studies & Leonard D. Schaeffer Chair in Health Policy Studies, Brookings Institution, Washington, DC, USA; Vicki L. Seyfert-Margolis, PhD, Senior Advisor, Science Innovation and Policy, Office of the Chief Scientist, Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD, USA
||SECOND PLENARY SESSION: HEALTH REFORM IN THE US: WILL STATE HEALTH INSURANCE EXCHANGES IMPROVE THE EFFICIENCY AND AFFORDABILITY OF HEALTH CARE IN THE US?
Moderator/Speaker: Susan Dentzer, MA, Editor-in-Chief, Health Affairs, Bethesda, MD, USA
Speakers: John E. McDonough, DrPH, MPA, Professor of the Practice of Public Health, Director of the Center for Public Health Leadership, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA; Joshua M. Sharfstein, MD, Secretary, Maryland Department of Health and Mental Hygiene, Baltimore, MD, USA
||THIRD PLENARY SESSION: PERFORMANCE-BASED RISK-SHARING ARRANGEMENTS: GOOD RESEARCH PRACTICES FOR DESIGN, IMPLEMENTATION AND EVALUATION
Speakers: Lou Garrison, PhD, Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington School of Pharmacy, Seattle, WA, USA; Adrian Towse, MA, MPhil, Director, Office of Health Economics, London, UK
|For sponsorship, exhibit, advertising and symposium opportunities, see: ISPOR 17th Annual International Meeting »
Value in Health Volume 14, Issue 8 On-Line
Value in Health »
|Highlighted in this issue:
||ISPOR Task Force Reports–Establishing and Reporting Evidence of the Content Validity of Newly-Developed Patient-Reported Outcome (PRO) Instruments for Medical Product Evaluation: Good Research Practices Task Force Reports Parts 1 and 2
||Economic Evaluation: Cost-Utility Analyses of Diagnostic Laboratory Tests: A Systematic Review
||Clinical Outcomes Assessment–Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research: How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size
||Patient-Reported Outcomes–Response Burden and Questionnaire Length: Is Shorter Better? A Review and Meta-analysis
||Preference-Based Assessment–EQ-5D for the Assessment of Health-Related Quality of Life and Resource Allocation in Children: A Systematic Methodological Review
||Health Policy Analysis–The National Institute for Health and Clinical Excellence Single Technology Appraisal Process: Lessons from the First 4 Years
ISPOR CONNECTIONS Vol. 17 No. 6 2011 On-Line
ISPOR CONNECTIONS Vol. 17 No. 6 »
ISPOR Health Policy, Value Based Health Care Working Group
The ISPOR Health Policy, Value Based Health Care Working Group presented a workshop at the ISPOR 14th Annual European Congress in Madrid, Spain, entitled, “Moving Towards Value Based Health Care In Different Constituencies: A Presentation On Behalf Of The ISPOR Value Based Health Care Special Interest Group.” To view the presentation, see: ISPOR Health Policy, Value Based Health Care Working Group »
ISPOR Distance Learning Program Now in Portuguese!
The ISPOR Latin America Consortium Distance Learning & On-Site Training Subcommittee announces the launch of the Portuguese language ISPOR Distance Learning Program. For more information, see: ISPOR Distance Learning Program »
ISPOR Bosnia-Herzegovina Regional Chapter
The ISPOR Bosnia-Herzegovina Chapter has now translated the ISPOR Book of Terms into Bosnian and is now available for purchase. For more information and to order, see: ISPOR Bosnia-Herzegovina Regional Chapter »
ISPOR Egypt Regional Chapter International Pricing Workshop
The ISPOR Egypt Chapter co-organized and presented during the International Pricing Workshop held December 6-7, 2011, Cairo, Egypt. For workshop agenda, see:
ISPOR Egypt Regional Chapter »
ISPOR India Regional Chapter
The ISPOR India Chapter Executive Committee member, Professor Anita Kotwani, PhD, MSc, BSc, of the Vallabhbhai Patel Chest Institute, University of Delhi, organized “Dissemination of Findings of WHO funded Survey on Medicine Prices and Availability in National Capital Territory of Delhi,” held on December 2, 2011 at University of Delhi. For more details, see: ISPOR India Regional Chapter »
ISPOR Indonesia Regional Chapter
The ISPOR Indonesia Chapter President, Professor Ahmad Fuad Afdhal, PhD, and chapter member, Professor Hasbullah Thabrany, PhD, are developing the pharmacoeconomic guidelines (PE) of Indonesia. The 2nd PE Guidelines meeting was held on November 7-8, 2011, with the Director for Pharmaceutical Development and Medical Devices of Indonesia, Enko Sosialine, attending. For information, see: ISPOR Indonesia Regional Chapter »
ISPOR South Korea Regional Chapter
The ISPOR South Korea Chapter held a Short Course on utility methods on December 9, 2011, with over 60 attendees. For more information, see: ISPOR South Korea Regional Chapter »
ISPOR Taiwan Regional Chapter
The ISPOR Taiwan Chapter held the 2011 Annual Conference and Symposium on December 17, 2011. The conference focused on health economic evaluation, HTA and health care decision making. For information, see: ISPOR Taiwan Regional Chapter »
Presentations from the EUnetHTA Conference, “HTA in national and cross-border healthcare in Europe,” held 8-9 December 2011, Gdansk, Poland, are now available at: http://www.eunethta2011.pl/pl/-presentations
ISPOR Good Outcomes Research Practices & Issues Index
93,000 PAGE VIEWS IN 2011
The ISPOR Good Outcomes Research Practices & Issues Index provides consensus documents on key outcomes research methods with over 30 documents on economic evaluations, comparative effectiveness research, modeling, preference-based methods, and risk-benefit methods.
ISPOR Good Outcomes Research Practices & Issues Index »
ARCHeS Innovator – Realistic HEOR Simulations in <24 Hours
Need to answer complex questions regarding treatment efficacy, possible outcomes, and costs in target groups with cardio-metabolic risk conditions?
The Archimedes Healthcare Simulator (ARCHeS) runs health economics and outcomes simulations in less than 24 hours and provides the tools to analyze the results.
Download a 57-page Model Description Report at: archimedesmodel.com/arches-24h
Career Opportunity in Patient Reported Outcomes
For more than 30 years, Genentech, now a member of the Roche group, has been at the forefront of the biotechnology industry, using human genetic information to develop novel medicines for serious and life-threatening diseases. Today, Genentech is among the world's leading biotech companies, with multiple therapies on the market for cancer and other serious medical conditions.
The Global Development Division is seeking a Principal Patient Reported Outcomes. This position will maximize the value of multiple agents within a therapeutic area by leading and developing Patient Reported Outcome (PRO) strategies for molecules during early clinical development. The successful candidate will:
- Work cross-functionally with several departments to develop PRO strategies
- Ensure relevant PRO endpoints and study design for registration clinical trial programs meet the needs of global regulatory agencies and key stakeholders
- Identify PRO instruments and evaluate measurement and psychometric properties of the instruments
- Work with external key opinion leaders and regulatory agencies to obtain guidance on PRO strategies
- Contribute to the design, implementation, and management of registration clinical trials containing PROs including the development of the PRO sections of study concept documents, study protocols, statistical analysis plans, clinical study reports and other development documents
- Develop and/or validate instruments for PRO as needed
- Adapt and validate instruments for use in different patient populations, including cultural adaptations and translations
- Work with Global Scientific Communications to develop publication plan that is integrated with overall publication strategy to communicate PRO information to physicians, patients, payers and policy makers
- Manage vendors including scope of work development, contract initiation and project milestones, timelines, deliverables and budgets
Requirements: An advanced degree in Psychology, Epidemiology, Health Services Research, Outcomes Research or a related discipline is preferred. A minimum of five years of professional experience in PRO assessment and/or psychometric validation is required. The candidate must have familiarity and experience with the development and implementation of research strategies, as well as a strong understanding of research methodology and statistics.
We aim to provide employees with a stimulating and collaborative environment where they can make important contributions to medicine and thrive as professionals. Our unique culture is characterized by a commitment to science, a dedication to patients and a respect for individuals and their contributions. To learn more about this opportunity, please visit: http://www.roche.com/careers.htm, and reference job ID# 00385724. Genentech is an equal opportunity employer.
January 19, 2012
ISPOR 17th Annual International Meeting Call for Abstracts Deadline
February 10, 2012
ISPOR Research Excellence Award
February 10, 2012
ISPOR New Investigator Award